NeuroscienceMolecular TherapyPeer-reviewed
ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice
Kristen H. Schuster, Annie J. Zalon, Danielle M. DiFranco…·Hayley S. McLoughlin
This study shows that ASO treatment rescues oligodendrocyte dysfunction in SCA3 mice by targeting mutant ATXN3, suggesting potential for glial-targeted therapies in neurodegenerative diseases.
24 citations